New combo may boost stem cell harvest for myeloma patients
NCT ID NCT05087212
First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested whether adding plerixafor to the standard drug G-CSF helps collect enough stem cells for a transplant in people with multiple myeloma. Fifty-three adults in remission joined the study. The goal was to see if this combination could collect the needed cells in fewer sessions, making the process safer and more efficient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Sites
China, China
Conditions
Explore the condition pages connected to this study.